Dr. Mark Dedomenico, a cardiovascular surgeon, played a role in developing the procedure known as Coronary Bypass Surgery along with Dr. Lester Sauvage. Working together as two of the initial founders of The Hope Heart Institute, they also created some of the most significant developments in heart surgery. These included the creation of an artificial heart valve called the Guided Flow Aortic Value used around the world for many years and the Sauvage Bionit Arterial Grafts used to replace damaged or atherosclerotic arteries that are still used today. Dr. Dedomenico’s work has also taken him into the areas of genetics, metabolic disorders, nutrition, exercise physiology, behavior medication, anti-aging and stem cells.
In the late 1980’s, Dr. Dedomenico began a new research project devoted to the treatment of early stage metabolic disease to prevent individuals from later needing cardiovascular surgery or medications to control hypertension, high cholesterol and diabetes. The research led to the creation of the 20/20 LifeStyles program. In 2002, 20/20 LifeStyles was selected as a credentialed provider of Microsoft’s weight-management program.
Dr. Dedomenico’s research and work with 20/20 LifeStyles remains ongoing with a staff of 215 professionals. He has formulated successful long term treatment methods of obesity, hyperlipidemia, hypertension, diabetes, depression, fibromyalgia, binge eating disorders and arthritis. Additionally, Dr. Dedomenico is currently involved in a major stem cell research project in conjunction with Dr. Wayne McIlwraith of Colorado State University. They are growing tendons, controlling osteoarthritis and they hope to grow heart muscle in the near future.
In addition to his experience as a practicing surgeon, Dr. Dedomenico spent many years overseeing one of the country’s largest and most respected privately-held companies, Golden Grain Macaroni Company, the producer of many well-loved consumer products, including Rice-a-Roni, Mission and Golden Grain pasta, Ghirardelli chocolates and Vernell’s Fine Candies. That company was sold in 1986.
Gordon Cohen MD, PhD, MBA, is a Professor of Practice in the Department of Bioengineering at Arizona State University. Until March 2016, Dr. Cohen was Professor and Vice-Chair of Surgery, the Julien I.E. Hoffman Endowed Chair of Cardiac Surgery, and the Chief of the Division of Pediatric Cardiothoracic Surgery at University of California, San Francisco (UCSF) School of Medicine. In addition, Dr. Cohen was the Chief of Strategic Program Development for the UCSF Benioff Children’s Hospital.
Prior to his tenure at UCSF, Dr. Cohen was Chief of the Division of Cardiothoracic Surgery and Surgical Director of the cardiac transplant program at Seattle Children's Hospital. He was also co-Director of Seattle Children's Heart Center. He was a Professor in the Department of Surgery and was the Associate Division Chief of Cardiothoracic Surgery at the University of Washington. Prior to that, Dr. Cohen was a Cardiothoracic Surgeon Consultant at Great Ormond Street Hospital in London and a Senior Lecturer at the University College London.
Dr. Cohen is also the Co-Founder and previous Chief Medical Officer of 98point6, a Seattle based early-stage technology health care company working on the next generation of primary care. He currently serves as a member of their Medical Advisory Board. Dr. Cohen was also a consultant to the NCAA as a member of their sudden cardiac death committee.
Dr. Cohen's clinical interests include complex neonatal repairs, pediatric heart, heart-lung and lung transplantation, mechanical cardiac assist, and heart failure. Dr. Cohen received his MD from Tulane University School of Medicine and earned a PhD in pharmacology from UCLA in 1996. His PhD advisor, Dr. Louis Ignarro, received the Nobel Prize in 1998. Dr. Cohen received his MBA from the University of Tennessee, School of Business. He completed residencies in Cardiothoracic surgery at the University of Washington, School of Medicine and in general surgery at UCLA Medical Center. Dr. Cohen is a Fellow of the American College of Surgeons, a member of the highly prestigious American Surgical Association, as well as numerous other professional societies. Highly respected by his peers, Dr. Cohen was named to the list of the US News & World Report "Top Doctors", which denotes the top one percent of physicians in the nation practicing a given specialty.
Dr. Cohen recently joined KIRO Radio for a weekly segment, "Paging Dr. Cohen". Follow his segment and additional health and wellness tips on Twitter @PagingDrCohen.
Board of Directors
The Hope Heart Institute is governed by a volunteer Board of Directors, which guides the overall strategic direction and approves The Hope's major financial commitments.